M Franken

Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands

Anouk Jochems, Maartje G. Schouwenburg, B Leeneman et al. · European Journal of Cancer · 2016 · 107 citations

Medicine, Oncology, Surgery +16

SIMILARITIES AND DIFFERENCES BETWEEN FIVE EUROPEAN DRUG REIMBURSEMENT SYSTEMS

M Franken, Maïté Le Polain, Irina Cleemput et al. · International Journal of Technology Assessment in Health Care · 2012 · 74 citations

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +16

Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

J Gaultney, M Franken, Siok Swan Tan et al. · Journal of Clinical Pharmacy and Therapeutics · 2012 · 50 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial

Evalyn E.A.P. Mulder, Karlijn de Joode, Saskia Litière et al. · BMC Cancer · 2021 · 50 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences

Saskia de Groot, Naomi van der Linden, M Franken et al. · Value in Health · 2016 · 45 citations · Full text

Computing, Biomedical Informatics, Health Informatics +16